--- a +++ b/processing/MACCROBAT/23468586.ann @@ -0,0 +1,201 @@ +T1 Age 2 13 23-year-old +T2 Sex 14 19 woman +T3 Disease_disorder 38 58 carnitine deficiency +E1 Disease_disorder:T3 +T4 History 38 58 carnitine deficiency +T5 Sign_symptom 85 92 dyspnea +E2 Sign_symptom:T5 +T6 Sign_symptom 97 104 fatigue +E3 Sign_symptom:T6 +T7 Detailed_description 74 84 exertional +R1 MODIFY Arg1:T7 Arg2:E2 +T8 Disease_disorder 147 161 cardiomyopathy +E4 Disease_disorder:T8 +T9 Age 165 177 age 10 years +T10 Detailed_description 135 146 nonischemic +R2 MODIFY Arg1:T10 Arg2:E4 +T11 Disease_disorder 226 239 heart failure +E5 Disease_disorder:T11 +T12 Detailed_description 215 225 congestive +R3 MODIFY Arg1:T12 Arg2:E5 +T13 Diagnostic_procedure 244 274 transthoracic echocardiography +E6 Diagnostic_procedure:T13 +T14 Diagnostic_procedure 276 279 TTE +E7 Diagnostic_procedure:T14 +R4 IDENTICAL Arg1:E7 Arg2:E6 +T16 Disease_disorder 315 317;319 330 LV dysfunction +E8 Disease_disorder:T16 +T15 Disease_disorder 297 313;319 330 left ventricular dysfunction +E9 Disease_disorder:T15 +R5 IDENTICAL Arg1:E8 Arg2:E9 +T17 Severity 290 296 severe +R6 MODIFY Arg1:T17 Arg2:E9 +R7 MODIFY Arg1:E9 Arg2:E7 +T18 Sign_symptom 203 211 symptoms +E10 Sign_symptom:T18 +R8 MODIFY Arg1:E5 Arg2:E10 +T19 Diagnostic_procedure 350 371 total carnitine level +E11 Diagnostic_procedure:T19 +T20 Lab_value 376 385 <3 μmol/L +R9 MODIFY Arg1:T20 Arg2:E11 +T21 Diagnostic_procedure 424 444 free carnitine level +E12 Diagnostic_procedure:T21 +T22 Lab_value 449 458 <3 μmol/L +R10 MODIFY Arg1:T22 Arg2:E12 +* OVERLAP E11 E8 E12 E15 +* OVERLAP E5 E6 +T23 Date 165 177 age 10 years +E13 Date:T23 +* OVERLAP E13 E10 E4 +T24 Disease_disorder 526 546 carnitine deficiency +E14 Disease_disorder:T24 +T25 Disease_disorder 493 507 cardiomyopathy +E15 Disease_disorder:T25 +R11 CAUSE Arg1:E14 Arg2:E15 +T26 Duration 554 562 5 months +E16 Duration:T26 +T27 Medication 579 600 carnitine supplements +E17 Medication:T27 +* OVERLAP E16 E17 +T28 Diagnostic_procedure 606 621;641 647 total carnitine levels +E18 Diagnostic_procedure:T28 +T29 Diagnostic_procedure 626 647 free carnitine levels +E19 Diagnostic_procedure:T29 +T30 Lab_value 665 674 86 μmol/L +T31 Lab_value 679 688 48 μmol/L +R12 MODIFY Arg1:T30 Arg2:E18 +R13 MODIFY Arg1:T31 Arg2:E19 +T32 Diagnostic_procedure 729 746 systolic function +E20 Diagnostic_procedure:T32 +T33 Biological_structure 712 728 left ventricular +R14 MODIFY Arg1:T33 Arg2:E20 +T34 Lab_value 793 798 34.7% +T35 Medication 929 957 carnitine supplement regimen +E21 Medication:T35 +T36 Detailed_description 895 919 intermittently compliant +R15 MODIFY Arg1:T36 Arg2:E21 +T37 Date 983 1011 6 months before presentation +E22 Date:T37 +T38 Diagnostic_procedure 1037 1058 free carnitine levels +E23 Diagnostic_procedure:T38 +T39 Diagnostic_procedure 1017 1032;1052 1058 total carnitine levels +E24 Diagnostic_procedure:T39 +T40 Lab_value 1074 1083 18 μmol/L +T41 Lab_value 1088 1097 17 μmol/L +R16 MODIFY Arg1:T40 Arg2:E24 +R17 MODIFY Arg1:T41 Arg2:E24 +T42 Diagnostic_procedure 768 789 fractional shortening +E25 Diagnostic_procedure:T42 +T43 Lab_value 751 761 normalized +R19 BEFORE Arg1:E17 Arg2:E18 +* OVERLAP E18 E19 E20 +R20 SUB_PROCEDURE Arg1:E25 Arg2:E20 +R21 MODIFY Arg1:T43 Arg2:E20 +R22 MODIFY Arg1:T34 Arg2:E25 +T44 Duration 853 875 over the past 10 years +E26 Duration:T44 +* OVERLAP E26 E21 +T46 Clinical_event 815 824 admission +E28 Clinical_event:T46 +T47 Diagnostic_procedure 1127 1130 TTE +E29 Diagnostic_procedure:T47 +T48 Diagnostic_procedure 1143 1169 cardiac magnetic resonance +E30 Diagnostic_procedure:T48 +T49 Diagnostic_procedure 1171 1174 CMR +E31 Diagnostic_procedure:T49 +R23 IDENTICAL Arg1:E31 Arg2:E30 +R25 BEFORE Arg1:E29 Arg2:E30 +T51 Diagnostic_procedure 1227 1238 LV function +E32 Diagnostic_procedure:T51 +T52 Diagnostic_procedure 1209 1212 TTE +E33 Diagnostic_procedure:T52 +T53 Lab_value 1220 1226 normal +R26 MODIFY Arg1:T53 Arg2:E32 +R27 SUB_PROCEDURE Arg1:E32 Arg2:E33 +T54 Disease_disorder 1260 1274 LV hypertrophy +E34 Disease_disorder:T54 +T55 Detailed_description 1249 1259 concentric +T56 Severity 1243 1247 mild +R28 MODIFY Arg1:T56 Arg2:E34 +R29 MODIFY Arg1:T55 Arg2:E34 +R30 MODIFY Arg1:E34 Arg2:E33 +T57 Diagnostic_procedure 1316 1323 LV size +E35 Diagnostic_procedure:T57 +T58 Lab_value 1309 1315 normal +R32 MODIFY Arg1:T58 Arg2:E35 +T59 Diagnostic_procedure 1316 1318;1328 1336 LV function +E36 Diagnostic_procedure:T59 +* OVERLAP E36 E35 E37 +R33 MODIFY Arg1:T58 Arg2:E36 +T60 Diagnostic_procedure 1364 1378 wall thickness +E37 Diagnostic_procedure:T60 +T61 Lab_value 1354 1363 increased +R34 MODIFY Arg1:T61 Arg2:E37 +T62 Biological_structure 1386 1391;1408 1412 basal wall +T63 Biological_structure 1396 1412 mid lateral wall +R35 MODIFY Arg1:T62 Arg2:E37 +R36 MODIFY Arg1:T63 Arg2:E37 +T64 Diagnostic_procedure 1414 1437 end-diastolic thickness +E38 Diagnostic_procedure:T64 +T65 Distance 1439 1445 1.6 cm +R37 MODIFY Arg1:T65 Arg2:E38 +T66 Diagnostic_procedure 1467 1497 delayed gadolinium enhancement +E39 Diagnostic_procedure:T66 +T67 Disease_disorder 1555 1575 sudden cardiac death +E40 Disease_disorder:T67 +T68 Family_history 1555 1575 sudden cardiac death +T69 Diagnostic_procedure 1586 1606 myocardial structure +E41 Diagnostic_procedure:T69 +T70 Lab_value 1577 1585 abnormal +R38 MODIFY Arg1:T70 Arg2:E41 +T71 Family_history 1577 1606 abnormal myocardial structure +T72 Disease_disorder 1612 1638 underlying disease process +E42 Disease_disorder:T72 +T73 Family_history 1612 1638 underlying disease process +T74 Therapeutic_procedure 1655 1693 implantable cardioverter-defibrillator +E43 Therapeutic_procedure:T74 +T75 Detailed_description 1642 1654 dual-chamber +R39 MODIFY Arg1:T75 Arg2:E43 +T50 Diagnostic_procedure 1181 1203 gadolinium enhancement +E44 Diagnostic_procedure:T50 +R24 SUB_PROCEDURE Arg1:E44 Arg2:E31 +R40 AFTER Arg1:E28 Arg2:E26 +R41 BEFORE Arg1:E21 Arg2:E22 +* OVERLAP E22 E24 E23 +R42 BEFORE Arg1:E24 Arg2:E29 +T76 History 135 161 nonischemic cardiomyopathy +T77 History 203 211 symptoms +T78 History 215 239 congestive heart failure +T79 History 244 274 transthoracic echocardiography +T80 History 290 330 severe left ventricular (LV) dysfunction +T81 History 350 371 total carnitine level +T82 History 424 444 free carnitine level +* OVERLAP E2 E3 +T83 History 493 507 cardiomyopathy +T84 History 526 546 carnitine deficiency +R18 BEFORE Arg1:E14 Arg2:E16 +T85 History 579 600 carnitine supplements +T86 History 606 621;641 647 total carnitine levels +T87 History 626 647 free carnitine levels +T88 History 712 746 left ventricular systolic function +T89 History 768 789 fractional shortening +T90 Detailed_description 1348 1353 focal +R43 MODIFY Arg1:T90 Arg2:E37 +R44 BEFORE Arg1:E25 Arg2:E28 +T45 Diagnostic_procedure 1295 1298 CMR +E27 Diagnostic_procedure:T45 +#1 AnnotatorNotes E33 Should label as coreference if referring to previously mentioned TTE? +R31 AFTER Arg1:E44 Arg2:E33 +* OVERLAP E33 E29 +R45 BEFORE Arg1:E33 Arg2:E27 +* OVERLAP E27 E31 +#2 AnnotatorNotes E27 Should label as coreference if refer to previous CMR? +R46 SUB_PROCEDURE Arg1:E36 Arg2:E27 +R47 SUB_PROCEDURE Arg1:E35 Arg2:E27 +R48 SUB_PROCEDURE Arg1:E37 Arg2:E27 +R49 SUB_PROCEDURE Arg1:E38 Arg2:E37 +T91 Detailed_description 1460 1466 patchy +R50 MODIFY Arg1:T91 Arg2:E39 +R51 SUB_PROCEDURE Arg1:E39 Arg2:E37 +R52 BEFORE Arg1:E39 Arg2:E43 +R53 BEFORE Arg1:E1 Arg2:E2